Gulmira Akhmetova

Dr. Gulmira Akhmetova

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2025 in Molecules
Verified
Journal Article
Open access
PDF file
GAGulmira Akhmetova
Gulmira Akhmetova
UIUlzhalgas Issayeva
Ulzhalgas Issayeva
KPKaldybay D. Praliyev
Kaldybay D. Praliyev
IKIlya S. Korotetskiy
Ilya S. Korotetskiy
TSTulegen Seilkhanov
Tulegen Seilkhanov
NZNatalya Zubenko
Natalya Zubenko
Cyanohydrin synthesis, as the simplest preparative method for introducing a carboxyl group into a piperidine molecule, has been used to obtain potentially biologically active piperidinecarboxylic acids, which have alkyl and arylalkyl radicals at the nitrogen atom of the piperidine ring. Hydrochlorides of cyclopropanecarboxylic acid esters based on piperidinecarboxylic acids, as well as hydrochlorides of fluorobenzoic acid esters of N-substituted piperidines, have been synthesized. The purpose of this study was to search for antiviral drugs among new piperidine derivatives. The structure of the synthesized compounds was studied by NMR methods, including COSY (1H-1H), HMQC (1H-13C) and HMBC (1H-13C) techniques. The values of chemical shifts, multiplicities, and integrated intensities of 1H and 13C signals in one-dimensional NMR spectra were determined. The results of COSY (1H-1H), HMQC (1H-13C), and HMBC (1H-13C) revealed homo- and heteronuclear interactions, confirming the structure of the studied compounds. The antiviral and cytotoxic activities of the synthesized compounds were studied. The antiviral activity in vitro was determined according to the therapeutic regimen against the influenza A/Swine/Iowa/30 (H1N1) virus on the MDCK cell model. The cytotoxicity of the studied substances in vitro was assessed using the MTT test. Based on the results of the antiviral activity against the influenza A virus, it can be concluded that all substances are effective against the influenza A/H1N1 virus compared to the commercial preparations Tamiflu and Rimantadine.

30 September 2026 in Reports of the NAS RK
Verified
Journal Article
Open access
PDF file
UIUlzhalgas Issayeva
Ulzhalgas Issayeva
GAGulmira Akhmetova
Gulmira Akhmetova
KPKaldybay D. Praliyev
Kaldybay D. Praliyev
AMAigul Erbosynovna Malmakova
Aigul Erbosynovna Malmakova
TSTulegen Seilkhanov
Tulegen Seilkhanov
Relevance. Despite notable progress in the development of new antibacterial agents, antimicrobial resistance, including multidrug resistance (MDR), remains one of the most serious challenges of modern medicine. MDR refers to the simultaneous resistance of pathogens to several drugs, which significantly complicates treatment strategies. The rapid increase in infections caused by resistant microorganisms is occurring against the background of considerable difficulties in creating fundamentally new and effective medicines. Therefore, the search for and development of novel anti-infective and antimicrobial compounds is highly relevant. The aim of this study was to develop a production technology for a highly effective antimicrobial agent of the piperidine series, 1-benzyl-4-(p-fluorobenzoyloxyimino) piperidine hydrochloride (AIP-15), and to evaluate its cytotoxicity under laboratory conditions. In vitro cytotoxicity was assessed using monolayer MDCK cell cultures. The quantitative toxic effect of the studied compound was determined by the MTT assay after 72 hours of exposure. Based on the obtained experimental data, CC₅₀ values were calculated to assess the safety profile of the compound. As a result of the in vitro cytotoxicity study using the MDCK cell culture model, it was shown that its value for the AIP-15 compound is 0.7 mg/ml. This work presents a four-stage technological scheme for obtaining AIP-15 as an active pharmaceutical substance. The developed technology provides a consistent and structured approach to its synthesis. Additionally, the cytotoxic properties of AIP-15 were evaluated in vitro, confirming its biological safety within the studied concentrations.

27 January 2026 in Molecules
Verified
Journal Article
Open access
PDF file
KPKaldybay D. Praliyev
Kaldybay D. Praliyev
GAGulmira Akhmetova
Gulmira Akhmetova
UIUlzhalgas Issayeva
Ulzhalgas Issayeva
SRSamir Anis Ross
Samir Anis Ross
MOManas Toktassynovich Omyrzakov
Manas Toktassynovich Omyrzakov
NZNatalya Zubenko
Natalya Zubenko
The cyclic adamantane framework possesses unique properties such as bulkiness, symmetry, and high lipophilicity. Research aimed at discovering new pharmaceutical agents within the adamantane series continues. In the present work, a targeted modification was carried out to combine two pharmacophore fragments—adamantane and piperidine—within a single molecule. Based on a series of N-substituted piperidin-4-ones, the corresponding secondary alcohols were obtained by reduction with sodium borohydride in isopropanol and subsequent acylation of these alcohols with adamantane carbonyl chloride yielded the corresponding adamantane-carboxylate esters. The structure of the synthesized compounds was studied by NMR methods, including COSY (1H-1H), HMQC (1H-13C) and HMBC (1H-13C) techniques. The values of chemical shifts, multiplicities, and integrated intensities of 1H and 13C signals in one-dimensional NMR spectra were determined. The results of COSY (1H-1H), HMQC (1H-13C), and HMBC (1H-13C) revealed homo- and heteronuclear interactions, confirming the structure of the studied compounds. The cytotoxic activities of the synthesized compounds were studied. It was found that the synthesized substituted piperidines bearing an adamantane fragment exhibit in vitro antimicrobial and antifungal activity against museum microbial strains (Escherichia coli ATCC 8739, Staphylococcus aureus ATCC 6538-P, Candida albicans ATCC 10231, Cryptococcus neoformans) and demonstrate significant advantages over the reference drugs used in clinical practice, such as fluconazole and ampicillin. These compounds are therefore recommended for further in-depth studies.

15 June 2022 in Chemical Journal of Kazakhstan
Verified
Journal Article
Closed access
UIUlzhalgas Issayeva
Ulzhalgas Issayeva
GAGulmira Akhmetova
Gulmira Akhmetova
KPKaldybay D. Praliyev
Kaldybay D. Praliyev
UDUbaidilla Datkhayev
Ubaidilla Datkhayev
MOManas Toktassynovich Omyrzakov
Manas Toktassynovich Omyrzakov
KNKaraganda PhytochemistryJSC NIH
Karaganda PhytochemistryJSC NIH
The chemistry of organofluorine compounds, before the eyes of one generation, has turned from a small branch of organic chemistry into a large independent branch of exceptionally important theoretical and practical significance. Numerous studies have confirmed the high biological activity of a number of fluorine-containing organic compounds, as a result of which such drugs as fluoroquinolone antibiotics, risperidone, fluorophenazine, haloperidol, etc. have been created and are successfully used. Among amide derivatives, substances with antibacterial, anticonvulsant, analgesic and antifungal properties have been found. The purpose of this work is to develop ways to obtain a number of new potentially biologically active fluorine-containing amides based on morpholine, and to study their biological activity. Results and discussion: on the basis of cyclic amine - morpholine, by acylation with para-, meta-, ortho-fluorobenzoyl chlorides, reaction according to Schotten-Bauman, the corresponding amides of para-, meta-, ortho-fluorobenzoic acids were synthesized. The reaction was carried out in absolute benzene with cooling and the ratio of amine: acylating agent = 2:1. Inclusion complexes of compounds with b-cyclodextrin have been obtained. The composition and structure of the synthesized compounds were confirmed by data of elemental analysis and IR, NMR spectroscopy, individuality - by thin-layer chromatography. The synthesized compounds under the codes ПМП-4 - ПМП-6 were studied in an in vitro experiment for antimicrobial activity. All compounds exhibit pronounced antibacterial activity against the presented gram-positive and gram-negative test strains, in particular, they exhibit moderate activity against the gram-positive strain of Staphylococcus aureus ATCC 6538. The compound ПМП-6 exhibits moderate activity against gram-positive bacteria Bacillus subtilis and moderate antibacterial action against the gram-negative test strain Escherichia coli ATCC 25922. The compound ПМП-6 also has antifungal activity against the yeast fungus Candida albicans ATCC 10231.